BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8432 related articles for article (PubMed ID: 11398059)

  • 1. [Computed tomography evaluation of metastasis of cutaneous melanoma].
    Potente G; Cantisani C; Cantisani V; Bottoni U; Calvieri S; Andreoli GM; Arduini F; Guerrisi R
    Radiol Med; 2001 Apr; 101(4):275-80. PubMed ID: 11398059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
    Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
    Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
    Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
    Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography in the detection of abdominal metastases from malignant melanoma.
    Silverman PM; Heaston DK; Korobkin M; Seigler HF
    Invest Radiol; 1984; 19(4):309-12. PubMed ID: 6480308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sentinel lymph nodes in cutaneous melanoma: the experience in the Florence area].
    Urso C; Borgognoni L; Vaggelli L; Giannini A; Salvadori A; Zini E; Reali UM
    Pathologica; 2003 Jun; 95(3):133-9. PubMed ID: 12968307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic patterns and metastatic sites in mucosal melanoma: a retrospective study.
    Grözinger G; Mann S; Mehra T; Klumpp B; Grosse U; Nikolaou K; Garbe C; Clasen S
    Eur Radiol; 2016 Jun; 26(6):1826-34. PubMed ID: 26373757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.
    Ribuffo D; Cavalieri L; De Vita F; Massa R; Prosperi D; Tuccimei M; Scuderi N
    J Exp Clin Cancer Res; 2001 Mar; 20(1):11-5. PubMed ID: 11370816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
    Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
    J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
    Abdel-Rahman O
    Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).
    Balch CM; Soong SJ; Murad TM; Smith JW; Maddox WA; Durant JR
    J Clin Oncol; 1983 Feb; 1(2):126-34. PubMed ID: 6668496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma.
    Kamath D; Rapaport D; DeConti R; Cruse CW; Wells K; Glass F; Messina J; Fenske N; Brobeil A; Berman C; Puleo C; Reintgen D
    J Fla Med Assoc; 1997 Mar; 84(3):182-7. PubMed ID: 9143170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staging of regional lymph nodes in melanoma patients by means of 99mTc-MIBI scintigraphy.
    Alonso O; Martínez M; Delgado L; De León A; De Boni D; Lago G; Garcés M; Fontes F; Espasandín J; Priario J
    J Nucl Med; 2003 Oct; 44(10):1561-5. PubMed ID: 14530467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?
    Vidal-Sicart S; Pons F; Puig S; Ortega M; Vilalta A; Martín F; Rull R; Palou JM; Castel T
    Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):362-6. PubMed ID: 12634963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in 1,521 melanoma patients with distant metastases.
    Barth A; Wanek LA; Morton DL
    J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
    Clark PB; Soo V; Kraas J; Shen P; Levine EA
    Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
    Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
    J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine imaging of asymptomatic melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease.
    Miranda EP; Gertner M; Wall J; Grace E; Kashani-Sabet M; Allen R; Leong SP
    Arch Surg; 2004 Aug; 139(8):831-6; discussion 836-7. PubMed ID: 15302691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole body PET/CT for initial staging of choroidal melanoma.
    Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
    Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence behavior in early-stage cutaneous melanoma: pattern, timing, survival, and influencing factors.
    Tas F; Erturk K
    Melanoma Res; 2017 Apr; 27(2):134-139. PubMed ID: 28099368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline staging in cutaneous malignant melanoma.
    Hafner J; Schmid MH; Kempf W; Burg G; Künzi W; Meuli-Simmen C; Neff P; Meyer V; Mihic D; Garzoli E; Jungius KP; Seifert B; Dummer R; Steinert H
    Br J Dermatol; 2004 Apr; 150(4):677-86. PubMed ID: 15099363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 422.